Preventing misleading claims: Ads for diabetes, oncology drugs may need approval

The government is looking to regulate advertisements for anti-diabetes, sex hormone, and oncology drugs by amending the Drugs and Cosmetics Rules, 1945. Proposed changes include requiring prior approval for advertising Schedule G drugs. Public feedback is being solicited for the next 45 days.